Overview
This book contains a series of contributions from internationally renowned academics with special expertise in one or other diseases which collectively are grouped under the heading myeloproliferative disorders. There have been many recent developments in understanding the pathophysiology and a number therapeutic innovations in this area. A feature of this book is the speed with which it has been produced - an important factor in this rapidly moving field.
Full Product Details
Author: J.V. Melo ,
J. Goldman
Publisher: Springer-Verlag Berlin and Heidelberg GmbH & Co. KG
Imprint: Springer-Verlag Berlin and Heidelberg GmbH & Co. K
Edition: 2007 ed.
Dimensions:
Width: 18.90cm
, Height: 1.90cm
, Length: 24.60cm
Weight: 0.714kg
ISBN: 9783642421129
ISBN 10: 3642421121
Pages: 354
Publication Date: 13 December 2014
Audience:
Professional and scholarly
,
Professional & Vocational
Format: Paperback
Publisher's Status: Active
Availability: Manufactured on demand
We will order this item for you from a manufactured on demand supplier.
Reviews
From the reviews: ""... a superb summary of the topic, is a modern synthesis of Dameshek’s adventurous thinking. ... Myeloproliferative Disorders is an important contribution to hematology. It arrives at a time when the study and treatment of these important diseases is at a crossroads, a time when hematologists everywhere have come to expect that the next great leap forward will come soon. For me, this book will sit on the shelf next to the first edition of Dameshek’s Leukemia. ..."" (Robert Schwartz, New England Journal of Medicine, 356/ 24, June 2007) ""First identified and named by William Dameshek in 1951, myeloproliferative disorders have become ‘landmarks in the history of malignant disease … on which progress in understanding and treating other malignancies … and indeed solid tumors can be based.’ … it ‘should be of interest to medical students who find the specialty of hematology truly fascinating.’ For other physicians and for patients, this reference provides a needed understanding of avant-garde medical research."" (William H. Wehrmacher, JAMA, Vol. 298, 2007)
From the reviews: .. . a superb summary of the topic, is a modern synthesis of Dameshek s adventurous thinking. ... Myeloproliferative Disorders is an important contribution to hematology. It arrives at a time when the study and treatment of these important diseases is at a crossroads, a time when hematologists everywhere have come to expect that the next great leap forward will come soon. For me, this book will sit on the shelf next to the first edition of Dameshek s Leukemia. ... (Robert Schwartz, New England Journal of Medicine, 356/ 24, June 2007) First identified and named by William Dameshek in 1951, myeloproliferative disorders have become landmarks in the history of malignant disease on which progress in understanding and treating other malignancies and indeed solid tumors can be based. it should be of interest to medical students who find the specialty of hematology truly fascinating. For other physicians and for patients, this reference provides a needed understanding of avant-garde medical research. (William H. Wehrmacher, JAMA, Vol. 298, 2007)
